Get the latest tech news
Apple Watch Pulse Oximetry Can Be Reactivated Through Software in 2028 or With Successful Appeal
Apple has been selling the Apple Watch Series 9 and Apple Watch Ultra 2 without the blood oxygen monitoring feature in the U.S. since mid-January,...
As part of the process to get approval to sell Apple Watch Series 9 and Ultra 2 models without pulse oximetry enabled, Apple had to provide the code disabling the feature and test devices to Masimo. The Exclusion Order Enforcement Branch of the U.S. Customs and Border Patrol ultimately decided that disabling pulse oximetry in the Apple Watch Series 9 and Ultra 2 was enough to avoid infringing on Masimo patents, allowing those models to be offered for sale at Apple retail stores in the U.S. Masimo CEO Joe Kiani said in January that he had not spoken with Apple, and while he would be open to settling, an apology and an "honest dialogue" would need to be part of any settlement discussion.
Or read this on Mac Rumors
